Instituting a Green Zone for Elective Surgery During the Second Wave of COVID-19.
covid-19
elective surgery
green zone
morbidity
mortality
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
accepted:
15
11
2021
entrez:
20
12
2021
pubmed:
21
12
2021
medline:
21
12
2021
Statut:
epublish
Résumé
Objective Elective surgery came to a standstill during the first wave of COVID-19. The safe resumption of elective surgery with COVID-19 prevalent in the community remains a significant challenge. The aim of this study was to look into the outcomes of elective general surgery in a dedicated 'Green Zone (GZ)' during the second wave of COVID-19 in the United Kingdom. Method A 'Green Zone' pathway, meant to provide a COVID-free environment, was created. A retrospective review of prospectively collected data was done on consecutive patients who underwent an elective general surgical procedure at a single NHS trust over a six-month period (September 1, 2020, to February 28, 2021). The primary outcome was 30-day COVID-19 mortality. Secondary outcomes included 30-day non-COVID-19 mortality, readmissions, and complications. Results The study included 331 patients with a median age of 55 years (interquartile range, IQR, 41-67); 169 (51%) were females. The majority of the patients were American Society of Anaesthesiologists grade 2 (ASA 2; n=177, 53%) followed by ASA 3 (n=76, 23%). Forty-seven patients (14%) had been shielding earlier in the year. Most of the cases were day cases (n=224, 67%). There was no 30-day COVID-19 or non-COVID-19 mortality. One patient developed COVID-19 three weeks after the index operation. Thirty-day readmission and complication rate were 4% (n=14) and 6% (n=21). Most of the complications were Clavien-Dindo grade 2 (n=10, 3%) followed by an equal number of grades 1 and 3b (n=5, 1.5%). Conclusion This study has shown that a dedicated 'Green Zone' elective operating pathway is safe and feasible provided a balanced risk assessment approach is adopted.
Identifiants
pubmed: 34926055
doi: 10.7759/cureus.19584
pmc: PMC8672239
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e19584Informations de copyright
Copyright © 2021, Iqbal et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Br J Surg. 2020 Aug;107(9):1091-1093
pubmed: 32383479
Anaesthesia. 2021 Nov;76(11):1454-1464
pubmed: 34371522
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
BMJ. 2020 Mar 18;368:m1106
pubmed: 32188602
Int J Surg. 2020 Jul;79:156-161
pubmed: 32447002
Int J Surg. 2020 Dec;84:57-65
pubmed: 33122153
Int J Surg. 2020 Jul;79:180-188
pubmed: 32454253
Ann Med Surg (Lond). 2020 Nov;59:245-250
pubmed: 33042534
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Br J Anaesth. 2021 Aug;127(2):196-204
pubmed: 34148732
Br J Surg. 2020 Sep;107(10):1250-1261
pubmed: 32350857